Defining the asthma-COPD overlap syndrome in a COPD Cohort

Chest

Volumn 149, Issue 1, 2016, Pages 45-52

  Cosio, Borja G ^a   Soriano, Joan B ^b   López Campos, Jose Luis ^c   Calle Rubio, Myriam ^d   Soler Cataluna, Juan Jose ^e   De Torres, Juan P ^f   Marín, Jose M ^g   Martínez Gonzalez, Cristina ^h   De Lucas, Pilar ⁱ   Mir, Isabel ^j   Peces Barba, Germán ^k   Feu Collado, Nuria ^l   Solanes, Ingrid ^m   Alfageme, Inmaculada ⁿ   Casanova, Ciro ^o,p  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^f HOSPITAL ARNAU DE VILANOVA   (Spain)

^g UNIVERSITY CLINIC OF NAVARRA   (Spain)

^h HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

ⁱ HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^j HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^k HOSPITAL SON LLÀTZER   (Spain)

^l Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^m UNIVERSITY OF CÓRDOBA   (Spain)

ⁿ HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^o HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^p HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

more..

Author keywords

Asthma; COPD; Eosinophils

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID DERIVATIVE; LONG ACTING DRUG; MUSCARINIC RECEPTOR BLOCKING AGENT; SALBUTAMOL; THEOPHYLLINE; BRONCHODILATING AGENT;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; ASTHMA COPD OVERLAP SYNDROME; BODY MASS; BRONCHODILATOR TEST; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPD ASSESSMENT TEST; DIAGNOSTIC TEST; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EOSINOPHIL COUNT; EXERCISE CAPACITY INDEX; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL PARAMETERS; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE VALUE; SURVIVAL TIME; SYMPTOM; SYNDROME; COMPLICATION; EOSINOPHIL; FORCED EXPIRATORY VOLUME; LEUKOCYTE COUNT; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

AGED; ASTHMA; BRONCHODILATOR AGENTS; COHORT STUDIES; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SYNDROME;

EID: 84954180942     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.15-1055     Document Type: Article

References (19)

1. Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest. 2003;124(2):474-481
2. Marsh SE, Travers J, Weatherall M, et al. Proportional classifications of COPD phenotypes [published correction appears in Thorax. 2014;69(7):672] Thorax. 2008;63(9):761-767
3. Weatherall M, Travers J, Shirtcliffe PM, et al. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J. 2009;34(4):812-818
4. Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011;48(3):279-285
5. Andersn H, Lampela P, Nevanlinna A, Synjkangas O, Keistinen T. High hospital burden in overlap syndrome of asthma and COPD. Clin Respir J. 2013;7(4):342-346
6. Hardin M, Silverman EK, Barr RG, et al; COPDGene Investigators. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12:127
7. Miravitlles M, Soler-Catalua JJ, Calle M, Soriano JB. Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Eur Respir J. 2013;41(6):1252-1256
8. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). Diagnosis of Asthma, COPD and Asthma-COPD overlap syndrome (ACOS). Global Initiative for Asthma website. http://www.ginasthma. org/. Accessed June 19, 2015
9. Soler-Catalua JJ, Coso B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-Asthma in COPD. Arch Bronconeumol. 2012;48(9):331-337
10. Lpez-Campos JL, Peces-Barba G, Soler-Catalua JJ, et al; En Nombre del Grupo de Estudio CHAIN. Chronic obstructive pulmonary disease history assessment in Spain: a multidimensional chronic obstructive pulmonary disease evaluation. Study methods and organization. Arch Bronconeumol. 2012;48(12):453-459
11. Miller MR, Hankinson J, Brusasco V, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26(2): 319-338
12. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26(4): 720-735
13. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005-1012
14. Hardin M, Cho M, McDonald ML, et al. The clinical and genetic features of COPD-Asthma overlap syndrome. Eur Respir J. 2014;44(2):341-350
15. Iwamoto H, Gao J, Koskela J, et al. Differences in plasma and sputum biomarkers between COPD and COPDasthma overlap. Eur Respir J. 2014;43(2): 421-429
16. Menezes AM, Montes de Oca M, Prez-Padilla R, et al; PLATINO Team. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-Asthma. Chest. 2014;145(2):297-304
17. Bafadhel M, McKenna S, Terry S, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo controlled trial. Am J Respir Crit Care Med. 2012;186(1):48-55
18. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347-365
19. Gibson PG, McDonald VM. Asthma-COPD overlap 2015: now we are six. Thorax. 2015;70(7):683-691